91
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Outcomes and Risk Factors for Complications in Cataract Patients with Hepatitis C Virus Infection

ORCID Icon, , , , &
Pages 492-498 | Received 25 Feb 2022, Accepted 26 Sep 2022, Published online: 04 Oct 2022

References

  • Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22(34):7824–7840. doi:10.3748/wjg.v22.i34.7824.
  • Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000;20(1):1–16. doi:10.1055/s-2000-9506.
  • Reid M, Price JC, Tien PC. Hepatitis C virus infection in the older patient. Infect Dis Clin North Am. 2017;31(4):827–838. doi:10.1016/j.idc.2017.07.014.
  • Yoshida K, Nakano H, Yoshitomi F, Oshika T. Prevalence of seropositivity for hepatitis C virus in cataract patients and the general population. J Cataract Refract Surg. 2002;28(10):1789–1792. doi:10.1016/S0886-3350(02)01335-4.
  • Lin SY, Lin CL, Ju SW, et al. Increasing risk of cataract in HCV patients receiving anti-HCV therapy: a nationwide cohort study. PLoS One. 2017;12(3):e0173125. doi:10.1371/journal.pone.0173125.
  • Naeem SS, Siddiqui EU, Kazi AN, Khan S, Abdullah FE, Adhi I. Prevalence of hepatitis ‘B’ and hepatitis ‘C’ among preoperative cataract patients in Karachi. BMC Res Notes. 2012;5(1):492. doi:10.1186/1756-0500-5-492.
  • Rewri P, Sharma M, Vats DP, Singhal A. Seroprevalence, risk associations, and cost analysis of screening for viral infections among patients of cataract surgery. Indian J Ophthalmol. 2018;66(3):394–399. doi:10.4103/ijo.IJO_726_17.
  • Gaskin GL, Pershing S, Cole TS, Shah NH. Predictive modeling of risk factors and complications of cataract surgery. Eur J Ophthalmol. 2016;26(4):328–337. doi:10.5301/ejo.5000706.
  • Miller DC, Christopher KL, Patnaik JL, et al. Posterior capsule rupture during cataract surgery in eyes receiving intravitreal anti-VEGF injections. Curr Eye Res. 2021;46(2):179–184. doi:10.1080/02713683.2020.1795884.
  • Park S, Choi NK. Hepatitis virus infection and age-related cataract. Sci Rep. 2017;7(1):13089. doi:10.1038/s41598-017-13283-6.
  • Ku JY, Sharma A. Pegylated interferon and ribavirin therapy for hepatitis C causing cataract. Clin Exp Ophthalmol. 2009;37:743–745.
  • Farel C, Suzman DL, McLaughlin M, et al. Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin. Aids. 2004;18(13):1805–1809. doi:10.1097/00002030-200409030-00009.
  • Shimazaki J, Tsubota K, Fukushima Y, Honda M. Detection of hepatitis C virus RNA in tears and aqueous humor. Am J Ophthalmol. 1994;118(4):524–525. doi:10.1016/S0002-9394(14)75807-6.
  • Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology. 2004;126(2):586–597. doi:10.1053/j.gastro.2003.11.020.
  • Varma SD, Chand D, Sharma YR, Kuck JF Jr., Richards RD. Oxidative stress on lens and cataract formation: role of light and oxygen. Curr Eye Res. 1984;3(1):35–57. doi:10.3109/02713688408997186.
  • Reddy AK, Patnaik JL, Miller DC, Lynch AM, Palestine AG, Pantcheva MB. Risk factors associated with persistent anterior uveitis after cataract surgery. Am J Ophthalmol. 2019;206:82–86. doi:10.1016/j.ajo.2019.02.016.
  • Schulman JA, Liang C, Kooragayala LM, King J. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology. 2003;110(2):437–442. doi:10.1016/S0161-6420(02)01741-4.
  • d’Alteroche L, Majzoub S, Lecuyer AI, Delplace MP, Bacq Y. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis. J Hepatol. 2006;44(1):56–61. doi:10.1016/j.jhep.2005.07.026.
  • Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002;36(5 Suppl 1):S35–46. doi:10.1053/jhep.2002.36806.
  • Ghany MG, Kleiner DE, Alter H, et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology. 2003;124(1):97–104. doi:10.1053/gast.2003.50018.
  • Atas M, Karatepe Hashas AS, Demircan S, et al. The Investigation of HCV RNA in tear fluid and aqueous humor in patients with anti-HCV antibody positive who underwent cataract surgery. Ocul Immunol Inflamm. 2016;24(3):297–301. doi:10.3109/09273948.2014.985386.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.